Denali Therap

Forecast & Rating20 analysts currently cover Denali Therap, with about 95.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $36.06, about 77.8% upside from the current price of $20.28. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 2.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Denali Therap closely still see room for the stock to rise. Data as of Sep 11, 2026; for reference only and not investment advice.